Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Incyte announces executive leadership changes, integrates U.S. teams
Incyte (NASDAQ: INCY) announced changes to its executive leadership team, appointing Pablo J. Cagnoni, M.D., as President and Global Head of Research and Development and Steven Stein, M.D., as Executive Vice President, Chief Medical Officer, and Head of Late-stage Development. Mohamed Issa, Pharm.D., was named Executive Vice President and Head of U.S. Commercial, overseeing the integration of U.S. Oncology and Immunology business units. These changes aim to enhance enterprise-wide strategic planning and operational execution, with Matteo Trotta leaving the company after a transition period.